Vladimir Misik

CEO SanaClis, Partner & Founder LongTaal
Vladimir Misik

PhD Biophysical Pharmacology, MSc. Physics
>30 years in biopharmaceutical research and development

  • Research cardiovascular pharmacology, and oncology
    Slovak Academy of Sciences, Bratislava, Slovakia
    The George Washington University Medical School, Washington DC, USA
    National Cancer Institute at NIH, Bethesda, MD, USA

  • Product development/CRO Quintiles
    VP & Head of global centralized operations center (GDN), India VP & Regional head of CEE and MENA clinical operations Head of Business development CEE and MENA

  • LongTaal, Founder & Partner www.longtaal.com
    Advanced clinical trial informatics and advisory services

  • SanaClis, CEO , www.sanaclis.eu
    Full-service European CRO

60 research articles and book chapters in peer-reviewed journals, currently focusing on various aspects of globalization of industry clinical trials

  • co-author of Clinical Trials in the Middle East and North Africa (in Global Clinical Trials, Elsevier 2011, eds. R Chin, M. Bairu)
  • V Misik, Shifting Sands: Global Clinical Trials: MENA Region, European Pharmaceutical Contractor, September 2011, pp 66-70
  • V Misik, Expected Growth of Industry-Sponsored Clinical Trials in the Middle East Benchmarked on other Global Regions, Quintiles White Paper, February 2012, pp 1-12
  • V Misik, Room to Bloom in MENA, Emerging Markets: MENA, SCRIP, April 2012, pp 20-22
  • V Misik,, RV Brady, M Bolecek and H Klech, Current Trends in Globalization of Industry-Sponsored Clinical Trials, Applied Clinical Research, Clinical Trials & Regulatory Affairs, 2014, 1, 56-66
  • Mišík V., Boleček M., Brady R.V. (2017) Ethical Considerations of Industry-Sponsored Clinical Trials in the Arab Region. In: Silverman H. (eds) Research Ethics in the Arab Region. Research Ethics Forum, vol 5. Springer, Cham, pp. 161-170
  • Misik V, Brady RV, Boleček M, Klech H: Recent trends in globalization of industry R&D clinical trials: are emerging markets losing their allure? Applied Clinical Research Clinical Trials and Regulatory Affairs, June 2017. Vol 4, pp. 175 - 182

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more